Recombinant Human ETV6 Protein，Strep & His

ETV6 (ETS variant 6) is a transcription factor that plays a critical role in hematopoiesis and the regulation of various developmental processes. Research on ETV6 has gained significant attention due to its involvement in several hematological malignancies, particularly in the context of chromosomal translocations that result in ETV6 fusion proteins. The most notable of these is the ETV6/RUNX1 fusion, which is commonly associated with childhood acute lymphoblastic leukemia (ALL). This fusion gene leads to the dysregulation of normal hematopoietic differentiation and proliferation, implicating ETV6 as a crucial player in the pathogenesis of leukemia. Additionally, ETV6 has been implicated in other cancers, such as breast cancer and solid tumors, suggesting its broader relevance in oncology. Understanding the molecular mechanisms by which ETV6 and its fusion proteins contribute to tumorigenesis can provide insights into potential therapeutic targets. Ongoing research aims to elucidate the pathways regulated by ETV6, the functional consequences of its mutations, and the potential for utilizing ETV6-related biomarkers in early diagnosis and treatment stratification for patients with related malignancies. Overall, the study of ETV6 and its associated proteins holds promise for developing targeted therapies and improving clinical outcomes in cancer treatment.